Skip to content

Intravenous Fluconazole prophylaxis in preterm neonates

Effectiveness of Intravenous Fluconazole prophylaxis on clinical outcome of preterm neonates during hospitalization

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014051411499N1
Enrollment
100
Registered
2014-08-03
Start date
2013-08-24
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Candidial sepsis. Neonatal candidiasis

Interventions

Intravenous fluconazole 3mg/kg for 6-weeks treatment with 3mg/kg dose of fluconazole as once every 3 days in first 2 weeks, once every 2days in second 2 weeks and every day in third 2 weeks.
Treatment - Drugs
Intravenous fluconazole 3mg/kg for 6-weeks treatment with 3mg/kg dose of fluconazole as once every 3 days in first 2 weeks, once every 2days in second 2 weeks and every day in third 2 weeks

Sponsors

Research Vice-Canceller of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 29 Days

Inclusion criteria

Inclusion criteria: Inclusion criteria : birth weight less than 1250 g Exclusion criteria: 1- major congenital anomalies 2- death in three days of life

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hospital stay days. Timepoint: measured at discharge. Method of measurement: in hospital days.;Assisted ventilation duration in days. Timepoint: measured at discharge. Method of measurement: days under assisted ventilation.

Secondary

MeasureTime frame
Mortality Rate. Timepoint: after death. Method of measurement: if died.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbdollah Jannatdoust

Tabriz University of Medical Sciences

jannatdousta@tbzmed.ac.ir+98 41 1553 9161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026